ARTICLE | Clinical News
Hiberix regulatory update
January 25, 2016 8:00 AM UTC
FDA approved an sBLA from GlaxoSmithKline for Hiberix to prevent invasive disease caused by Haemophilus influenza type B ( Hib) in children ages 6 weeks through 14 months. The Hib vaccine is now appro...